Francois Eyskens

Antwerpen, VLG, Belgium

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 40 publications

Long-term efficacy and safety of pegunigalsidase alfa administered every 4 weeks in adults with Fabry disease: results from up to 5 years of the BRIGHT F51 phase III, open-label extension study.

Long-term efficacy and safety of pegunigalsidase alfa administered every 4 weeks in adults with Fabry disease: results from up to 5 years of the BRIGHT F51 phase III, open-label extension study.

Journal: Orphanet journal of rare diseases

Published: November 12, 2025

Palliative Care for Children and Adults With Inherited Metabolic Disease in Europe: An Underutilised Service for Supportive Treatment and Care.

Palliative Care for Children and Adults With Inherited Metabolic Disease in Europe: An Underutilised Service for Supportive Treatment and Care.

Journal: Journal of inherited metabolic disease

Published: June 19, 2025

High-Resolution Mass Spectrometry Method for Targeted Screening and Monitoring of Fabry, Gaucher and ASMD Using Dried Blood Spots and Capitainers: Impact of Sample Matrix on Measurement Results.

High-Resolution Mass Spectrometry Method for Targeted Screening and Monitoring of Fabry, Gaucher and ASMD Using Dried Blood Spots and Capitainers: Impact of Sample Matrix on Measurement Results.

Journal: International journal of molecular sciences

Published: May 29, 2025

Unexplained splenomegaly as a diagnostic marker for a rare but severe disease with an innovative and highly effective new treatment option: A case report.

Unexplained splenomegaly as a diagnostic marker for a rare but severe disease with an innovative and highly effective new treatment option: A case report.

Journal: Molecular genetics and metabolism reports

Published: August 02, 2024

Left ventricular hypertrophy: do not forget Fabry disease. Diagnostic work-up and differential diagnosis.

Left ventricular hypertrophy: do not forget Fabry disease. Diagnostic work-up and differential diagnosis.

Journal: Acta cardiologica

Published: June 13, 2024

A phase III, open-label clinical trial evaluating pegunigalsidase alfa administered every 4 weeks in adults with Fabry disease previously treated with other enzyme replacement therapies.

A phase III, open-label clinical trial evaluating pegunigalsidase alfa administered every 4 weeks in adults with Fabry disease previously treated with other enzyme replacement therapies.

Journal: Journal of inherited metabolic disease

Published: February 23, 2024

What Mothers Know about Newborn Bloodspot Screening and the Sources They Use to Acquire This Knowledge: A Pilot Study in Flanders.

What Mothers Know about Newborn Bloodspot Screening and the Sources They Use to Acquire This Knowledge: A Pilot Study in Flanders.

Journal: Children (Basel, Switzerland)

Published: August 25, 2023

A new multiplex analysis of glucosylsphingosine and globotriaosylsphingosine in dried blood spots by tandem mass spectrometry.

A new multiplex analysis of glucosylsphingosine and globotriaosylsphingosine in dried blood spots by tandem mass spectrometry.

Journal: Molecular genetics and metabolism reports

Published: July 13, 2023

Metachromatic leukodystrophy: To screen or not to screen?

Metachromatic leukodystrophy: To screen or not to screen?

Journal: European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society

Published: December 12, 2022

Severe dilated cardiomyopathy as an unusual clinical presentation in an infant with sialidosis type II.

Severe dilated cardiomyopathy as an unusual clinical presentation in an infant with sialidosis type II.

Journal: JIMD reports

Published: September 19, 2022

Neurocognitive outcome and mental health in children with tyrosinemia type 1 and phenylketonuria: A comparison between two genetic disorders affecting the same metabolic pathway.

Neurocognitive outcome and mental health in children with tyrosinemia type 1 and phenylketonuria: A comparison between two genetic disorders affecting the same metabolic pathway.

Journal: Journal of inherited metabolic disease

Published: March 04, 2022

Vertebral Tongue-Like Deformity in Mucopolysaccharidosis VI.

Vertebral Tongue-Like Deformity in Mucopolysaccharidosis VI.

Journal: Journal of the Belgian Society of Radiology

Published: July 27, 2021

Showing 1-12 of 40

Last Updated: 09/26/2026